Mehran Makvandi

3PUBLICATIONS
37CO-AUTHORS
Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study.

Austin R Pantel, Sarah B Gitto, Mehran Makvandi

|Jul 21, 2022
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma.

Vandana Batra, Minu Samanta, Mehran Makvandi

|Dec 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response.

Aladdin Riad, Sarah B Gitto, Hwan Lee

Pageof 1

Frequent Collaborators

2 joint publications

Chia-Ju Hsieh

1 joint publications

Aladdin Riad

1 joint publications

Dalia K Omran

1 joint publications

Vandana Batra